Meghan Derenoncourt

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine”.

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine

Addiction(2024)10.1111/add.16600

N/A

0DataRank · unranked

12 citations

Junfeng Sun, Ashley Davis, Amelia Cover, Lily Sun, Catherine Gannon +9 more

“Stigma is our most powerful enemy”: Understanding opioid use disorder stigma and the role of peer support in rural Maryland

International Journal of Drug Policy(2025)10.1016/j.drugpo.2025.104924

N/A

0DataRank · unranked

6 citations

Caroline Sacko, Gordon Atkinson, Noah S. Triplett, M W Kihiuria, Miriam Sonn +7 more

Elevated rate of suicide risk in individuals with opioid use disorder

American Journal on Addictions(2025)10.1111/ajad.70027

N/A

0DataRank · unranked

0 citations

Elana Rosenthal, Sun Jung Kang, Rahwa Eyasu, Emade Ebah, Onyinyechi Ogbumbadiugha +15 more

Major barriers and facilitators of care for patients with infectious complications of opioid use disorder: A multi-site, qualitative analysis of expert stakeholders from the CHOICE protocol

Journal of Substance Use and Addiction Treatment(2025)10.1016/j.josat.2025.209778

N/A

0DataRank · unranked

0 citations

Meghan Derenoncourt, Christopher Brokus, John Stevens, Joseph Carpenter, Andrea Steck +11 more